eConsent

Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.

Redefine your clinical trials: Join us on October 25th for a live product spotlight on Castor’s eConsent solution.

eConsent plays a pivotal role in optimizing modern clinical trials, but the nuance around its adoption for pharmaceutical and medical device companies remains a consideration for implementation teams.

Our on demand webinar with Leanne Walsh from Northern Light Lifescience to dive into the process of eConsent adoption from sponsor to site.

Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges.

In this blog we cover how eConsent benefits trials and aligns with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models on the informed consent process.

Essity needed to recruit participants for a decentralized clinical trial. Deploying virtual methods with the help of Castor, the team was able to successfully create a trial ecosystem that was accessible to all participants. Castor allowed Essity to streamline its clinical operations while also making it easier for participants to navigate the journey from start to finish.

Listen to our CEO & Founder, Derk Arts, as he reflects on lessons learned from the BIO panel discussion and what to expect at DIA.

As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these trials more and more, researchers have come to appreciate the significance of establishing uniform approaches for evaluating and analyzing real-world data (RWD).

An avalanche of data from so many real-world sources is available today, with the promise of more data generated daily—so why not use it?